Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Daktronics stock crashed today after reporting a quarterly earnings miss. This article breaks down what happened, why...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Griffon (GFF) 2026 earnings season offers clues about growth and margins across its portfolio. This guide breaks down...
A hypothetical partnership could redirect USDC yield to buybacks, potentially lifting Hyperliquid's value. This guide...
Two oil giants linked to Guyana just posted a staggering combined profit. Here’s what investors need to know about pr...
SpaceX stock has swung wildly since its debut, raising a simple question for every investor: is spacex stock: $150? a...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
As the energy transition gains pace, nuclear power moves back into the spotlight. This article breaks down two stock ...
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
A high-stakes reminder that transportation investments hinge on cash flow, leverage, and portfolio balance. This piec...
Diana Shipping (DSX) could face a volatile 2026 cycle driven by freight rates, charter activity, and balance-sheet st...